Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 9, 2016, Pages 2460-2465

  Guo, Qinglan ^a,b,c   Tomich, Adam D ^a   McElheny, Christi L ^a   Cooper, Vaughn S ^a   Stoesser, Nicole ^d   Wang, Minggui ^b,c   Sluis Cremer, Nicolas ^a   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; ENZYME INHIBITOR; ESCHERICHIA COLI PROTEIN; FOSCARNET; FOSFOMYCIN; GLUTATHIONE TRANSFERASE;

AGED; ANALYSIS; ANTAGONISTS AND INHIBITORS; ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; SECRETION (PROCESS); URINE;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; FOSCARNET; FOSFOMYCIN; GENOME, BACTERIAL; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SEQUENCE ANALYSIS, DNA; URINE;

EID: 84995414186     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw177     Document Type: Article

References (30)

1. Karlowsky JA, Denisuik AJ, Lagace-Wiens PR et al. In vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study. Antimicrob Agents Chemother 2014; 58: 1252-6.
2. Johnson JR, Drawz SM, Porter S et al. Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and coresistance phenotype among recent Escherichia coli isolates from US veterans. Antimicrob Agents Chemother 2013; 57: 4856-60.
3. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-20.
4. Kahan FM, Kahan JS, Cassidy PJ et al. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 1974; 235: 364-86.
5. Castañeda-García A, Blázquez J, Rodríguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics 2013; 2: 217-36.
6. Thompson MK, Keithly ME, Sulikowski GA et al. Diversity in fosfomycin resistance proteins. Perspect Sci 2015; 4: 17-23.
7. Wachino J, Yamane K, Suzuki S et al. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 2010; 54: 3061-4.
8. Hou J, Huang X, Deng Y et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M b-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother 2012; 56: 2135-8.
9. Li Y, Zheng B, Li Y et al. Antimicrobial susceptibility and molecular mechanisms of fosfomycin resistance in clinical Escherichia coli isolates in mainland China. PLoS One 2015; 10: e0135269.
10. Lee SY, Park YJ, Yu JK et al. Prevalence of acquired fosfomycin resistance among extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 2012; 67: 2843-7.
11. Ho PL, Chan J, Lo WU et al. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 2013; 62: 1707-13.
12. Alrowais H, McElheny CL, Spychala CN et al. Fosfomycin resistance in Escherichia coli, Pennsylvania, USA. Emerg Infect Dis 2015; 21: 2045-7.
13. Ma Y, Xu X, Guo Q et al. Characterization of fosA5, a new plasmidmediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol 2015; 60: 259-64.
14. Shen P, Jiang Y, Zhou Z et al. Complete nucleotide sequence of pKP96, a 67850 bp multiresistance plasmid encoding qnrA1, aac(6′)-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae. J Antimicrob Chemother 2008; 62: 1252-6.
15. Doi Y, Hazen TH, Boitano M et al. Whole-genome assembly of Klebsiella pneumoniae coproducing NDM-1 and OXA-232 carbapenemases using single-molecule, real-time sequencing. Antimicrob Agents Chemother 2014; 58: 5947-53.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
17. Nakamura G, Wachino J, Sato N et al. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases. J Clin Microbiol 2014; 52: 3175-9.
18. Sidjabat HE, Paterson DL, Adams-Haduch JM et al. Molecular epidemiologyof CTX-M-producing Escherichia coli isolates at a tertiarymedical center in western Pennsylvania. Antimicrob Agents Chemother 2009; 53: 4733-9.
19. Li JJ, Spychala CN, Hu F et al. Complete nucleotide sequences of blaCTX-M-harboring IncF plasmids from community-associated Escherichia coli strains in the United States. Antimicrob Agents Chemother 2015; 59: 3002-7.
20. Stoesser N, Giess A, Batty EM et al. Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of communityversus hospital-associated transmission in an endemic setting. Antimicrob Agents Chemother 2014; 58: 7347-57.
21. Bonnin RA, Poirel L, Carattoli A et al. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 2012; 7: e34752.
22. Fiett J, Baraniak A, Izdebski R et al. The first NDM metallo-b-lactamaseproducing Enterobacteriaceae isolate in Poland: evolution of IncFII-type plasmids carrying the blaNDM-1 gene. Antimicrob Agents Chemother 2014; 58: 1203-7.
23. Tseng SP, Wang SF, Kuo CY et al. Characterization of fosfomycin resistant extended-spectrum b-lactamase-producing Escherichia coli isolates from human and pig in Taiwan. PLoS One 2015; 10: e0135864.
24. Jiang Y, Shen P, Wei Z et al. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. Int J Antimicrob Agents 2015; 45: 66-70.
25. Villa L, Guerra B, Schmoger S et al. IncA/C plasmid carrying blaNDM-1, blaCMY-16, and fosA3 in a Salmonella enterica serovar Corvallis strain isolated from a migratory wild bird in Germany. Antimicrob Agents Chemother 2015; 59: 6597-600.
26. Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415-9.
27. Endimiani A, Patel G, Hujer KM et al. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 2010; 54: 526-9.
28. Lu CL, Liu CY, Huang YTet al. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 2011; 55: 4295-301.
29. Samonis G, Maraki S, Rafailidis PI et al. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Future Microbiol 2010; 5: 961-70.
30. Rigsby RE, Rife CL, Fillgrove KL et al. Phosphonoformate: a minimal transition state analogue inhibitor of the fosfomycin resistance protein, FosA. Biochemistry 2004; 43: 13666-73.